Intestinal cell models their use in evaluating the metabolism and absorption of xenobiotics

S.T.P. Pharma Sciences

Volumn 7, Issue 4, 1997, Pages 259-269

  Boulenc, X ^a  

^a SANOFI   (France)

Author keywords

Drug intestinal absorption cell culture ; In vitro in vivo correlation; Intestinal differentiation; Intestinal drug metabolism; Intestinal models

Indexed keywords

XENOBIOTIC AGENT;

CELL DIFFERENTIATION; DRUG ABSORPTION; DRUG METABOLISM; HUMAN; HUMAN CELL; INTESTINE ABSORPTION; INTESTINE CELL; REVIEW; XENOBIOTIC METABOLISM;

EID: 0031544690     PISSN: 11571489     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (109)

1. HILLGREN K.M., KATO A. and BORCHARDT R.T In vitro systems for intestinal drug absorption Med. Res. Rev., 15,83109, 1995.
2. SMITH M.W Cell biology and molecular genetics of enterocyte différenciation Curr. Top. Membr. Transp., 39,153-179,1991.
3. HENDLE J Symbolae ad anatomia villaoim intestinatium imprimis eorum epithelii et vasorum lacteorum PhD Thesis, University of Berlin, 1837.
4. LABURTHE M., ROUYER-FESSARD C. and BAMMELTOFT S Receptor insulin-like growth factor I and II in rat gastrointestinal epithelium Am. J. Physiol., 254, G457-G462,1988.
5. GALLOT-PAYET N. and HUGON J.S EGF receptors in isolated adult mouse intestinal cells. Studies in vivo and in an organ culture Endocrinology., 116, 194-201, 1985.
6. GORDON J.I Intestinal epithelial differentiation : new insights from chimaeric and transgenic mice J. Cell. Biol., 108,11871194, 1989.
7. SCHWENK M Glucuronidation and sulfation in the gastrointestinal tract In : Intestinal Metabolism of Xenobiotics, Progress in Pharmacology and Clinical Pharmacology, A.S. Koster, E. Richter, F. Lauterbach and F. Hartmann Eds., Gustav Fisher, Stuttgart, 1989, pp. 155-169.
8. CHANDRASENA G., SUNITHA I., LAU C., NANTHAKUMAR N.N. and HENNING S.J Expression of sucrase-isomaltase mRNA along the villus crypt axis in the rat small intestine Cell. Mol. Bioi., 38, 243-254, 1992.
9. DAWSON J.R. and SCHWENK M Isolated epithelial cells. In : Intestinal Metabolism of Xenobiotics, Progress in Pharmacology and Clinical Pharmacology, A.S. Koster, E. Richter, F. Lauterbach and F. Hartmann Eds., Gustav Fisher, Stuttgart, 1989, pp. 21-36.
10. MOVER H.P Culture of human gastro-intestinal epithelial cells Proc. Soc. Exp. Biol. Med., 174, 11-15, 1983.
11. QUARONI A., WANDS J., TRELSTAD R.L. and ISSELBACHER K.J Epithelial cell cultures from rat small intestine. Characterization by morphologic and immunologie criteria J. Cell. Biol., 80, 248-265, 1979.
12. KEDINGER M., SIMON-ASSMAN P.M., LACROIX B., MARSEER A., HAURI M.P. and HAFFEN K Fetal mesenchyme induces différenciation of cultured intestinal endoderm and crypt cells Dev. Biol., 113, 474-483, 1986.
13. ADAMS J.S Specific internalization of 1,25 dihydrovitamin D3 by cultured intestinal epithelial cells J. Steroid. Biochem., 20, 857-862, 1984.
14. INUI K.I., QUARONI A., TILLOTSON L.G. and ISSELBACHER K.J Amino acid and hexase transport by cultured crypt cells from rat small intestine Am. J. Physiol., 239, C190-C196, 1980.
15. ZWEIBAUM A., LABURTHE M., GRASSET E. and LOUVARD D Use of cultured cell lines in studies of intestinal cell differentiation and function In : Handbook of Physiology, Section 6, Vol. IV, B.B. Rauner Ed., American Physiology Society, Bethesda, 1991, pp. 223-255.
16. FOGH J., FOGH J.M. and ORFEO T 127 cultured human colon cell lines producing tumors in nude mice J. Natl. Acad. Sei., 59, 221-226, 1977.
17. FOGH J. and TREMPE G New human cell lines. Human tumor cells in vitro J. Fogh Ed., Plenum Press, New York, 1975, pp. 115-141.
18. LABURTHE M., ROUSSET M., BOISSARD C., CHEVALIER G., DUPONTC., ZWEIBAUM A. and ROSSELIN G Vasoactive intestinal peptide : a potent stimulator 3'-5' monophosphate in gut carcinoma cell line in culture Proc. Nat. Acad. Sei. USA, 75,2772-2775, 1978.
19. MOSTOV K.E. and GLOBEL G A transmembrane precursor of secretory component. The receptor fortranscellulartransport of polymeric immunoglobulins J. Biol. Chem., 257, 1181611821, 1982.
20. COHENE.,TALMONA.,FAFFO.,DACHERA.andBENSHAUL Y Formation of tight junctions in epithelial cells. Induction by proteases in a human colon carcinoma cell line Exp. Cell. Res., 156, 103-116, 1985.
21. CHUNG Y.S., SONG I.S., ERICKSON R.H., SLEISENGER M.H. and KIM Y.S Effect of growth and sodium butyrate on brush border membrane-associated hydrolases in human colorectal cancer cell line Cancer Res., 45,2976-2982,1985.
22. CHANTRET I., BARBAT A., DUSSAULX F., BRATTAIN M.G. and ZWEIBAUM A Epithelial polarity, villin expression and enterocytic differentiation of cultured human colon carcinoma cells : a survey of twenty cell lines Cancer Res., 48, 19361942, 1988.
23. ARTURSSON A Cell culture as models for drug absorption across the intestinal mucosa Crit. Rev. Ther. Drug Carrier System, 8, 105-330, 1991.
24. GAN L.S., EADS C., NIEDERER!., BRIDGERS A., YANNI S., HSYU P.M., PRITCHARD F.J. andTHAKKER D Use of Caco2 as an in vitro intestinal absorption and metabolism model. Drug Dev. Ind. Pharrn., 20, 615-631, 1994.
25. ZWEIBAUM A Differentiation of human colon cancer cells. In : Pharmaceutical Applications of Cell and Tissue Culture to Drug Transport, G.X. Wilson, S.S. Davis, G. Ilium and A. Zweibaum Eds., Plenum Press, New York, 1991, pp. 27-38.
26. MATSUMOTO S.I., SAITO H., and INUI K I Transcellular transport of oral cephalosporins in human intestinal epithelial cells Caco-2 : Interaction with dipeptide transport systems in apical and basolateral membranes J. Phar. Exp. Ther., 270, 498-504, 1994.
27. GODEFROY O., HUET C., IBARRA C., DAUTRY-VARSAT A. and LOUVARD D Establishment of polarized endocytosis in differentiable intestinal HT29-18 subclones New Biol., 2,875886, 1990.
28. WILS P., LEGRAIN S., FRENOIS E., and SCHERMAN D. HT29-18C1 intestinal cells : a new model for studying the epithelial transport of drugs Biochem. Biophys. Acta., 1177, 134-138,1993.
29. WIKMAN A., KARLSSON J., CARLSTEDT I. and ARTURSSON P A drug absorpion model based on the mucus layer producing human intestinal goblet cell line HT29-H Pharm. Res., 10, 843-852,1993.
30. PINTO M., RABINE-LEON S., APPAY M.D., KEDINGER M., TRIADOU N., DUSSAULX E., LOUROIX B., SIMON-ASSMANN P., HAFFEN K., FOGH J. and ZWEIBAUM A Enterocyte-like differentiation and polarisation of the human colon carcinoma cell line Caco-2 in culture Biol. Cell., 47, 323-330, 1983.
31. HAURI H.P., STERCHI E.E., BIENZ D., FRANSEN J.A.M. and MARXER AExpression and intracellulartransport of microvillus membrane hydrolases in human intestinal epithelial cells J. Cell. Biol., 101,838-851, 1985.
32. BLAIS A., BISSONNETTE P. and BERTELOT A Common characteristics for Na+-dependant sugar transport in Caco-2 cells and human fetal colonJ. Membr. Biol., 99,113-125,1987.
33. CHANTRET I. and BARBAT A Différenciation des cellules cancéreuses coliques humaines en culture in vitro Ateliers de Formation de l'INSERM No. 67, Edition de l'INSERM, Paris, 1994.
34. ZWEIBAUM A Enterocytic differentiation of cultured human colon cancer cell lines : negative modulation of D-glucose In : lon-Gradient-Coupled Transport, F. Alvarado and C.H. Van As Eds., Elsevier, Amsterdam, 1986, pp. 345-353.
35. CHANTRET I., RODOLOSSE A., BARBAT A., DUSSAULX E., BROT-LAROCH A., ZWEIBAUM A., and ROUSSET M. Differential expression of sucrase-isomaltase in clones isolated from early and late passages of the cell line Caco-2 : evidence for glucose-dependent negative regulation J. Cell Sei., 107, 213-225, 1994.
36. HOWELL S., KENNY A.J. and TURNER A.J A survey of membrane peptidases in two human colonie cell lines, Caco-2 and HT29 Biochem. J., 284, 595-601, 1992.
37. DALL'OLIO F The expression of soluble and cell bound sialyltransferase in human colonie carcinoma Caco-2 cells correlates with the degree of enterocytic differentiation. Biochem. Bioph. Res. Commun., 184, 1409-1410, 1992.
38. BROCKHAUSEN P.A.R. and HERSCOVICI A. Glucosyltransferase changes upon differentiation of Caco-2 human colonie adenocarcinoma cells Cancer Res., 51,31363142, 1991.
39. NIV Y., BYRD J.C., HO S.B., DAHIYA R., and KIM Y.S Mucin synthesis and secretion in relation to spontaneous differentiation of colon cancer cells in vitro Int. J. Cancer, 50,147-152,1992.
40. FIELD F.J., ALBRIGHT E. and MATHUR S.N Regulation of cholesterol esterification by micellar cholesterol in Caco-2 cells J. Lipid Res., 28, 1057-1066, 1987.
41. LEVIN M.S., TALKAD V.D., GORDON J.I. and STENSON W.FTrafficking of exogenous fatty acids within Caco-2 cells. J. Lipid Res., 33, 323-331, 1992.
42. RIEHL T.E., TURK J. and STENSON W.F Metabolism of oxygenated dérivâtes of arachidonic acid by Caco-2 cells J. Lipid. Res., 33, 323-331, 1992.
43. ROTTMAN J.N. and GORDON J.I Comparison of the pattern of expression of rat intestinal'fatty aoidMTidf'iipMtain/human growth hormona fusion genes in cultured- intestinal epithelial cell lines and in the gut epithelium of tran'agsn'lc mice J. Biol. Chem., 26,. 119941 SOiDE,1993.
44. HiDALQO I.J. and BORCHARDT R.T. Transport of a large neutral amino acid (phenylalanine) in a human intestinalepithelial cell line : Caco-2 Biochem. Biophys. Aota., 1028, 25-30,1990 (a).
45. HIDALGO I.J. and BORCHARDT R.T Transport of bile acids in a human intestinal epithelial cell line, Caco-2 Biochem. Biophys. Acta., 1035, 67-103, 1990 (b).
46. SOUBA W.W., PAN M. and STEVENS B.R Kinetics of the sodium-dependent glutamine transporter in human intestinal cell confluent monolayers Biochem. Bioph. Res. Commun., 188,746-753, 1992.
47. DANT2IG A.H. and BERGIN L Carrier-mediated uptake of cephalexin in human intestinal cells Biochem. Bioph. Res. Commun., 155, 1082-1087, 1988.
48. DIX C.J., HASSAN I.F., OBRAY H.Y., SHAH R. and WILSON G The transport of vitamin B12 through polarized monolayers of Caco-2 cells Gastroenterol., 98,1277-1279,1990.
49. ANDERSON J..M., VAN ITALLIE C.M., PETERSON M.D., STEVENSON B.R., CAREW E.A. and MOOSEKER M.S Zo1 mRNA and protein expression during tight junction assembly in Caco-2 cells J. Cell. Biol., 109, 1047-1056,1989.
50. GRASSET E, PINTO M., DUSSAULX E., ZWEIBAUM A. and DESJEUX J.F.-Epithelial properties of human coloniccarcinoma cell line Caco-2 : electrical properties Am. J. Physiol., 247, C260-C267, 1984.
51. HIDALGO I.J., RAUB T.J. and BORCHARDT R.T. Characterization of the human colon carcinoma cell line (Caco2) as a model system for intestinal epithelial permeability. Gastroenterol., 96, 736-749,1989.
52. RAMOND M.J., MARTINO-PEIGNOUX M. and ERLINGER S. Dome formation in the human colon carcinoma cell line Caco2 in culture. Influence of ouabain and permeable supports. Biol. Cell., 54, 89-92, 1985.
53. ROUSSETM.,ROBINE-LEONS., DUSSAULX E., CHEVALIER C. and ZWEIBAUM A Glycogen storage in foetal and malignant epithelial cells of the human colon In : Frontiers of Gastrointestinal Research, Vol. 4, P. Rozen, S. Eidelmann and T. Eilats Eds., S. Karger AG, Basel, 1980, pp. 80-85
54. BOULENC X., MARTI E., JOYEUX H., ROQUES C., BERGER Y. and FABRE G Importance of the paracellular pathway for transport of a new bisphosphonate using the human Caco-2 monolayer model.-Biochem. Pharmacol.,46,1591-1600,1993.
55. DUMAS J L'absorption In : Traité de Biopharmacie et Pharmacocinétique, J.M. Aiache, J.G. Besner, P. Buri, P.P. Leblanc and M. Lesne Eds., Vigot, Paris, 1985, pp. 143-164.
56. KARALI T.T Gastrointestinal absorption of drugs Crit. Rev. Ther. Drug Carrier Syst., 6, 39-86,1989.
57. BARRY P.H. and DIAMOND J.M Effects of unstirred layer on membrane phenomena Physiol. Rev., 64, 763-872,1984.
58. MACADAM A The effect of gastro-intestinal mucus on drug absorption Adv. Drug Delivery Rev., 11, 201-220,1993.
59. WINNE D. and VERNHEYEN W Diffusion coefficient in native mucus gel of rat small intestine J. Pharm. Pharmacol, 42, 517-519, 1990.
60. HIDALGO IJ..H1LGREN K.M., GRASS G.M. and BORCHARDT R.T Characterization of the unstirred water layer in Caco-2 cell monolayers using a novel diffusion chamber Pharm. Res., 2, 222-227,1991.
61. INUI K.I, YAMAMOTO M and SAITO H Transepithelial transport of oral cephalosporins by monolayers of intestinal epithelial cell line Caco-2 : specific transport systems in apical and basolateral. membranes J. Pharmacol. Exp. Ther., 261, 195-201, 1992.
62. HU M., CHEN J., ZHU Y., DANTZIG A.H., STRATFORD R.E. Jr. and KUHFELD M.T Mechanism and kinetics of transcellular transport of a new β-lactam antibiotic, loraoarbef, across an intestinal epithelial membrane model system (Gaco-2) Pharm. Res., 11, 1405-1413, 1994.
63. HU M. and BORCHARDT R.T Mechanism of L-methyidopa tramped thwjpta 'miQiinlBifiiir.iafqtefiiaMiJd' intpijiij,intestinal upithBltalnCBlilfliCrtfcovaj/'' aaWjA, 7 13:i|il|tt,1990.
64. HU U>, ' CoW:piSisàri';afi:o!plart'0&aitolfeiti|éeii!Iih|tiWl:ne and Zidovu'llne in a human' intestinal épatheliall'fnoulal'iyàlam j. Pharm. SoUea,. 81-90,1993.
65. BURTOhlRS, GdURAPIfi;A..iiHll4ERiSA;B, arreH.Q N.F.H. Evidence fer a polàtlsmi effluxj system; for pepticte j,n::|the apical membrane of Cèco-2 cells'BiochefrvBfüprt. ,Res,Co., 190, 760-766, 1,993.
66. KARIiSSON J.,KUO S.W., ZITvJNIAK J. and'ARTURSSON P. Transport of celiprolol across human iBtestinalrepjthelial (Caco2) cells: mediation of secretion by multipletran&ppfilers including P-glycoprotein Br. J. PharmaeoK, 110, lio09-1,0t6,1993.
67. AUGUSTUM9 ;A.F., BRADSBAWi P., GANi;LSi. MENDREN W. and THAKKER D.R Evidenüefor/a polafizee.öJffiüix system in Caco-2 cells capable of modulating; eyclosporin A transport. Biochem. PharmacoL, 197, açotëèls,.; 1993.
68. PHUNG-BAV., WÄRNERY A,; SCERMAN DjandWILS P. Interaction of pristamycinl with P-glyooprotaiin in humlan intestinal epithelial cells Eur. J. Pham, jtiji, 187-192,1995,
69. WETTERieH U., :SPAHN4AWU|H H., MUTECHER E., TERAAG i., RO8CH W. and, kAÄiGUTH p Evidence for intestinal pathway.of Tanilol: enantfömers : conce.niriation- and dose-dependent absorption in vttr&md in\vivo.- Pharm. Res., 13,514-522,1996.
70. ARTURSSON. P. and MAGNUSÇON C Epitheltelitransport of drugs in cell culture. II : Effect of extracellular calcium concentration on the paracellular transport of drugs Of different lipophilicities across monolqysrs of intestinal iepithyial (Caco2) cells J. Pharrn. Sciences, ?fl(:595-600,1990.;
71. LIN J.H Dose-dépendance pharmacokinsties ; experimental observations and theoretical considerations Bioptiarm. Drug Disp., 15, 1-31,1994.
72. BOUL'ENC X., BREUL T., GAUTIER J.C., SAU0EMON P., JOYEUX H., ROQUES C., BERGER Y. and, FÄBRE G. Sodium laurylsuffate increases tiludironateparacellulartransport using human epithelial Caco-2 mönolayers Int. J, Pharm., 123, 71-83,1995.
73. ANDÇRBERG E.K., NYSTROM C. and ARTURSSON P. Epithelial transport of drugs in cell culture. VII : :Effects of pharmaceutical surfactant excipients, and bile acids on transepithfHal; permeability In monolayerslöf human intestinal epithelial (Caco-2) cells Pharm. Res., 81, .876-887,1992.
74. HURNI M.A. NOACH A.B.J., BLOM-ROOSEMALEN M.C.M., DE BOER1: A.G:, NAGELKERKE J.F. and BREIMER D.D. Permeability enhancement in Caco-2 cell mönolayers by sodium sallcylate and sodium taurodihydrofusidate : assessment of effect-;reverclfeilityfind imagifig of transeplthelial transport routes by confocal laser scanning microscopy J. Pharm; Exp. Ther. 267, 942949 1993.
75. RAEISSl S.D, and BORCHARDT R.T Cultured human colon carcinoma:pelis:(Gaco-2) as a model to study the mechanism by which pa|n)itol-CjLcarnitine enhances intestinal permeability of drugs S.T.P. Pharma Sei, 3,56-62,1993.
76. DREWEJ.,FRlCKERG,VONDERSCHERJ.andBEGLINGER C Enlefej/absorption of octreotirie : absorption enhancement by polyoX)iJethytene'24-Gho!esteFOl ther Br. J. Pharmacol., 108, £98-103,: 1998.
77. JOROENSEN .,L, ARTURSSON P, and BECMGAARD. Toxi,qolo§i|l ,and pfosorption ehhancing: effects ol'glycofurol 75 and sqdiij;(n:.glycocholate in .monolayers of human intestinal apithelialitbacoi-Scells Int. J/Pharm.9S,209-21'7,1993.
78. Urobel absortion noainofertent bymtediu michaiii ifat tyaeldsinlntestinal epithelial 4e;CpSC!9ll mpnolayers J, Phar/Exp. Ther., 275, 95804,:: liaiJSii i :
79. HOVJ3i:l|p ;L - Deug.delivery, studies in Caqo-2 monolayers. IV : Absorption., e'fîharïCër effects of cyclodextrins.1Pharm. Res./12;'iiâEiaSEï 1:9'95.
80. NERURKA M.M., BURTON P.S., and BORCHARDT R.TThe use of surfactants to enhance the permeability of peptides through Caco-2 cells by inhibition of the apical polarized efflux system Pharm. Res., 13, 528-534, 1996.
81. HOVGAARD L, BRONDSTED H., BUUR A. and BUNDGAARD H Drug delivery studies on Caco-2 monolayers. Synthesis, hydrolysis, and transport of O-cyclopropane carboxylic acid ester prodrugs of various -blocking agents Pharm. Res., 12, 387-392, 1995.
82. ARTURSSON P. and KARLSSON J Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem. Bioph. Res. Co., 175, 880-885, 1991.
83. WALTER E. and KISSEL T Heterogeneity in the human cell line Caco-2 leads to differences in transepithelial transport. Eur. J. Pharm. Sciences., 3, 215-230, 1995.
84. CHONG S., DANDO S.A., SOUCEK K.M., and MORRISON R.A In w'fropermeabilitythrough Caco-2 cells is notquantitavely predictive of in vivo absorption for peptide-like drugs absorbed via the dipeptide transporter system Pharm. Res., 13, 120123,1996.
85. COGBURN J.N., DONOVAN M.G. and SCHASTEEN C.S. Correlation of Caco-2 transport with human oral bioavailability. J. Contr. Release, 13, 314-315, 1990.
86. RUBAS W., JEJYK N. and CRASS G.M Comparison of the permeability characteristics of a human colonie epithelial (Caco2) cell line to colon of rabbit, monkey and dog intestine and human drug absorption Pharm. Res., 10, 113-118, 1993.
87. ARTURSSON P., UNGELL A.L. and LOFROTH JE Selective paracellular permeability in two models of intestinal absorption : cultured monolayers of human intestinal cells and rat intestinal segments Pharm. Res., 10, 1123-1129, 1993.
88. ARTURSSON P Epithelial transport of drugs in cell culture. A model for studying the passive diffusion of drugs over intestinal absortive (Caco-2) cells J. Pharm. Sei., 79, 476-482, 1990.
89. WILSON G., HASSAN l.F., DIX C.J., WILLIAMSON I., SHAL W.R., MACHAY M. and ARTURSSON P Transport and permeability properties of human Caco-2 cells : an in w'fromodel of the intestinal epithelial cell barrier J. Control. Release., 11, 25-40, 1990.
90. RANALDI G., ISLAM F. and SAMBUY Y Epithelial cells in culture as a model for the intestinal transport of antimicrobial agents Antimicrob. Agents Chemother., 36,1374-1381,1992.
91. KRISHNA D.R. and KLOTZ U Extrahepatic metabolism of drugs in humans Clin. Pharmacokinet, 26, 144-160, 1994.
92. PETERS W.H.N Purification and partial characterization of human intestinal gluthatione-S-transferase Biochem. Pharmacol., 37, 2288-2291, 1988.
93. PETERS W.H.M., NAGENGAST K.M. and VON TANGEREN J.H.M Gluthation-S-transferase, cytochrome P450 and uridine 5' diphosphate. Glucuronosyltransferase in human small intestine and liver Gastroenterology, 96, 783-789, 1989.
94. COMBES R.D Cytochromes P450, mixed function oxidases and formation of genotoxic metabolites by the intestinal tract. In : Intestinal Metabolism of Xenobiotics, A.S. Koster, E. Richter, F. Lauterbach and F. Hartmann Eds., Gustav Fisher, Stuttgart, 1989, pp. 119-141.
95. DE WAZIER l., CUGNENC P.H., YANG C.S., LEROUX J.P., and BEAUNE P Cytochrome P450 isozymes, epoxide hydrolases and glutathion S-transferases in rat and human, hepatic and extrahepatic tissues J. Pharm. Exp. Ther., 253. 387-394, 1990.
96. TRABER P.G., McDONNELL W.M., WANG W. and FLORENCE R Expression and regulation of cytochrome P450I genes (CYPIA1) and (CYPIA2) in the rat alimentary tract.- Biochem. Bioph. Res., 1171, 167-175, 1992.
97. McDONNELL W.M., SCHEIMAN J.M. and TRABER P.G. Induction of cytochrome P450IA genes (CYPIA) by omeprazole in the human alimentary tract Gastroentorology, 103, 15091516,1992.
98. BOULENC X., BOURRIE M., FABRE l., ROQUE C., JOYEUX H., BERGER Y. and FABRE G Regulation of cytochrome P450IA1 gene expression in a human intestinal cell line Caco2 J. Pharm. Exp. Ther., 263, 1471-1478, 1992.
99. ROSENBERG D. W. and LEFF T Regulation of cytochrome P450 in cultured human colonie cellsArch. Biochem.Biophys., 190,186-192,1993.
100. SERGEN-ENGELEN T., DELISTRIE V. and SCHEINER Y.J. Phase I and II biotransformations in living Caco-2 cells cultivated under serum-free conditions Biochem. Pharmacol., 46 (8), 1393-1401,1993.
101. KAMINSKY LS. and FASCO M.J Small intestinal cytochrome P450 Toxicology, 21, 407-422, 1992.
102. PRUEKARITANONT T., GORHAM L.M., HOCHMAN J.H., TRAN L.O. and VYAS K.P Comparative studies of drugmetabilizing enzymes in dog, monkey, and human small intestine, and in Caco-2 cells Drug Met. Disp., 24, 634-642,1996.
103. CARRIERE V., LESSUFFLEUR T., BARBAT A., ROUSSET M., DUSSAULT E., COSTET P., DE WAZIER I., BEAUNE P. and ZWEIBAUM A Expression of cytochrome P450 3A in HT29-MTX and Caco-2 clone TC7 FEBS Letters, 355, 147150,1994.
104. CAROI.,BOULENCX.,ROUSSETM.,MEUNIER V., BOURRIE M., JULIAN B., JOYEUX H., ROQUES C., BERGER Y. and FABRE G Charaterization of a newly isolated Caco-2 clone (TC7), as a model of transport process and biotransformation of drugs Int. J. Pharm., 116, 147-158, 1995.
105. PETERS W.H.M. and ROELOFS M.M.J Time-dependent activity and expression of glutathione S-transferases in the human colon adenocarcinoma cell line Caco-2 Biochem. J., 264,613-616, 1989.
106. PETERS W.H.M. and ROELOFS M.M.J Biochemical characterisation of resistance to mitoxantrone and adriamycin in Caco-2 human colon adenocarcinoma cells. A possible role of GST Cancer Res., 52, 1886-1890, 1992.
107. BARANCZYK-KUZMA A., GARREN J.A., HIDALGO J. and BORCHARDT R Substrate specificity and some properties of phenol suIfotransferase from human intestinal Caco-2 cells. Life Sei.,49, 1197-1206, 1991.
108. ABID A., BOUCHON I., SIEST G. and SAOLOVIC N. Glucuronidation in the Caco-2 human intestinal cell line : induction of UDP-glucuronosyltransferase 16 Biochem. Pharmacol., 50, 557-561,1995.
109. WIKMAN-LARHED A, and ARTURSSON P Coculture of intestinal goblet (HT29-H) and absorptive (Caco-2) cells for studies of drug and peptide absorption Eur. J. Pharm. Sciences, 3, 171-183, 1995.